Literature DB >> 3007688

Continuous human glioma-derived cell lines UC-11MG and UC-302MG. Morphologic, immunocytochemical and chromosomal characterization.

B H Liwnicz, G Archer, S W Soukup, R G Liwnicz.   

Abstract

Two continuous human glioma-derived cell lines, UC-11MG and UC-302MG were established in our laboratory. Both cell lines persistently showed cytologic features similar to those of their respective original tumors. UC-11MG expressed glial fibrillary acidic protein (GFAP) and S-100 protein. The cell lines were negative for factor VIII related antigen (FVIII/RAg) and positive for fibronectin and neuronal specific enolase (NSE). Electron microscopic studies of UC-11MG revealed intermediate filament; filopodia and pinocytic vesicles were present in both lines. Dibutyryl cAMP (dB-cAMP) caused inhibition of growth and marked shift in the morphology of UC-302MG toward spindle cells. The cytologic appearance of UC-11MG treated with dB-cAMP was altered less, but cells showed a stronger GFAP expression, with 'cable' formation. Doubling time was 41.0 +/- 6.4 hours for UC-11MG and 43.7 +/- 6.6 hours for UC-302MG. The karyotypes of both cell lines were aneuploid with chromosomal derangement and markers characteristic for each line.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007688     DOI: 10.1007/bf00165588

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Long term culture of normal and neoplastic human glia.

Authors:  J Pontén; E H Macintyre
Journal:  Acta Pathol Microbiol Scand       Date:  1968

2.  Morphological alterations and increase of S-100 protein in cultured human glioma cells deprived of serum.

Authors:  A Edström; K G Haglid; M Kanje; L Rönnbäck; E Walum
Journal:  Exp Cell Res       Date:  1974-02       Impact factor: 3.905

3.  Interferon effects on multiplication, cytoplasmic protein and GFAP content, and morphology in human glioma cells.

Authors:  K Korosue; I Takeshita; H Mannoji; M Fukui
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

4.  Cultured human glial and glioma cells.

Authors:  V P Collins
Journal:  Int Rev Exp Pathol       Date:  1983

Review 5.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

6.  Cytogenetic features of human neuroblastomas and cell lines.

Authors:  G M Brodeur; A A Green; F A Hayes; K J Williams; D L Williams; A A Tsiatis
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Biology of gliomas: potential clinical implications of glioma cellular heterogeneity.

Authors:  D D Bigner
Journal:  Neurosurgery       Date:  1981-09       Impact factor: 4.654

8.  Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases.

Authors:  F Giangaspero; P C Burger
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

9.  Characterization of an established human malignant glioma cell line: LN-18.

Authors:  A C Diserens; N de Tribolet; A Martin-Achard; A C Gaide; J F Schnegg; S Carrel
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

10.  Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines.

Authors:  F Gilbert; G Balaban; P Moorhead; D Bianchi; H Schlesinger
Journal:  Cancer Genet Cytogenet       Date:  1982-09
View more
  4 in total

1.  Alteration in p53 modulates glial proteins in human glial tumour cells.

Authors:  H S U; A Banaie; L Rigby; J Chen; H Meltzer
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

2.  Establishment of a human glioma cell line bearing a homogeneously staining chromosomal region and releasing alpha- and beta-type transforming growth factors.

Authors:  H Kanno; T Kuwabara; M Shinonaga; C C Chang; Y Tanaka; Y Sugio; H Morita; H Yasumitsu; M Umeda; Y Nagashima
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  A cell line of human malignant astrocytoma producing autocrine growth factor.

Authors:  K Arai; Y Horie; M Kurimoto; S Endoh; K Hiraga; A Takaku
Journal:  In Vitro Cell Dev Biol       Date:  1991-08

4.  Non-peptide antagonists, CP-96,345 and RP 67580, distinguish species variants in tachykinin NK1 receptors.

Authors:  A J Barr; S P Watson
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.